Role of angiotensin-converting enzyme inhibition in glucose metabolism and renal injury in diabetes. (Q54111188)

24 May 2018

review article

1 reference

title

Role of angiotensin-converting enzyme inhibition in glucose metabolism and renal injury in diabetes. (English)

1 reference

24 May 2018

author name string

M T Velasquez

1

1 reference

24 May 2018

S J Bhathena

2

1 reference

24 May 2018

J S Striffler

3

1 reference

24 May 2018

N Thibault

4

1 reference

24 May 2018

E Scalbert

5

1 reference

24 May 2018

publication date

1 December 1998

1 reference

24 May 2018

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

24 May 2018

volume

47

1 reference

24 May 2018

issue

12 Suppl 1

1 reference

24 May 2018

page(s)

7-11

1 reference

24 May 2018

The epidemiology of impaired glucose tolerance and hypertension.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Antihypertensive therapy with Ca2+. Antagonist verapamil and/or ACE inhibitor enalapril in NIDDM patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Hormonal and metabolic effects of enalapril treatment in hypertensive subjects with NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Angiotensin-Converting Enzyme Inhibitors and Insulin Sensitivity: Metabolic Effects in Hypertension, Diabetes, and Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Treating hypertension in non-insulin-dependent diabetes: a comparison of atenolol, nifedipine, and captopril combined with bendrofluazide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Lack of effects of angiotensin-converting enzyme (ACE)-inhibitors on glucose metabolism in type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Electrolyte changes and metabolic effects of lisinopril/bendrofluazide treatment. Results from a randomized, double-blind study with parallel groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Metabolic effects of doxazosin and enalapril in hypertriglyceridemic, hypertensive men. Relationship to changes in skeletal muscle blood flow.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Glucose and Lipid Metabolism During Long-Term Treatment with Cilazapril in Hypertensive Patients With or Without Impaired Glucose Metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Effect of dietary sucrose on the SHR/N-corpulent rat: a new model for insulin-independent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Long-term effects of perindopril on metabolic parameters and the heart in the spontaneously hypertensive/NIH-corpulent rat with non-insulin-dependent diabetes mellitus and hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Effects of perindopril on insulin sensitivity and plasma lipid profile in hypertensive non-insulin-dependent diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

The link between insulin resistance and hypertension. Effects of antihypertensive and antihyperlipidaemic drugs on insulin sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Modifications of glucose storage and oxidation in nonobese diabetics, measured by continuous indirect calorimetry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Muscle glycogen synthesis and disposition of infused glucose in humans with reduced rates of insulin-mediated carbohydrate storage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Effects of enalapril, losartan, and verapamil on blood pressure and glucose metabolism in the Cohen-Rosenthal diabetic hypertensive rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Structure and function of the kidney in diabetic glomerulosclerosis. Correlations between morphological and functional parameters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Renal changes in long-term type 1 (insulin-dependent) diabetic patients with and without clinical nephropathy: a light microscopic, morphometric study of autopsy material

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Structural-functional relationships in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Renal interstitial expansion in insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Effects of diabetes and insulin on expression of kallikrein and renin genes in the kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Renin and angiotensinogen expression during the evolution of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Perindopril ameliorates glomerular and renal tubulointerstitial injury in the SHR/N-corpulent rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

Vasoactive hormones and renal sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990363-8

10.1016/S0026-0495(98)90363-8

7 January 2021

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018